BMI1 and head and neck squamous cell carcinoma: The Cisplatin-resistant HNSCC cells showed a dose-dependent increase in the ALDHhighCD44high CSC fraction (Fig. 5A) as compared to the parent cell lines, likewise activation of STAT3 signaling and expression of Bmi-1 (Fig. 5B).